Product Profile

Oxilio

By Lifebloom

Oxilio is Lifebloom’s passive wheelchair–exoskeleton hybrid for assisted standing, balance and walking in rehabilitation.

Status Available
Product Type Passive
Body Area Lower Limb
Use Case Walking & Mobility
Available Pricing Not Public

Product Overview

Oxilio is Lifebloom’s passive wheelchair–exoskeleton hybrid for people with residual lower-limb function who need support to stand and walk. Its wheeled frame and mechanical bodyweight assistance support sit-to-stand transitions, balance and user-driven walking; connected sensors do not make it a motor-powered walking exoskeleton.

Oxilio is the physical device within Lifebloom One, which adds activity monitoring and clinician-directed rehabilitation tools. Lifebloom identifies Oxilio as a CE-marked Class I medical device. Initial healthcare orders and production were reported in November 2026, while a home-use offer remains in preparation.

Positioning & Buyer Fit

Positioning

A passive wheelchair–exoskeleton hybrid for supported standing and user-driven walking within a connected rehabilitation program.

Best For

Healthcare facilities assessing upright mobility and supervised rehabilitation for people who retain some lower-limb function.

Passive mechanical bodyweight assistance
assisted sit-to-stand
wheeled balance support
walking assistance

Use Case & Product Classification

Body Area
Product Type
Industry / Setting
Device Type

Passive wheelchair–exoskeleton hybrid

Claims & Evidence

Technical Highlights
  • Wheeled support frame and passive mechanical assistance. Connected tools track steps
  • standing activity and distance as part of Lifebloom One. Motor output
  • battery
  • device weight and dimensions are not adopted without model-specific manufacturer specifications.
Manufacturer-reported
Moderate source confidence

Lifebloom reports favorable preliminary rehabilitation outcomes. The reported stroke inpatient study was small and does not establish universal walking recovery or independently verified efficacy.

Certification & Regulatory Notes

Regulatory Status

Lifebloom identifies Oxilio as a CE-marked Class I medical device.

Notes

Manufacturer statement on CE marking and Class I classification; no independent regulatory file reviewed.

Pricing & Commercial Access

Pricing Not publicly listed

No official public price found

Pricing Status

Pricing Not Public

Currency

Not specified

Product sourcing support Need help assessing this product or comparing alternatives?

Tell us about your task, users, industry and region. We can help identify relevant products, suppliers and practical next steps.

Discuss your requirements

Sources & External Links

Product profiles are compiled from official and public sources. Pricing, availability, performance claims and deployment requirements may vary by region, configuration and distributor.
Stay Updated

Follow exoskeleton product launches, events and market notes

Get curated updates on new products, supplier activity, buyer guides and industry developments.

Join newsletter